Bullish
Medtronic plc (MDT) has expanded its partnership with cardiovascular intelligence software company Retia Medical to distribute the Argos Cardiac Outpu...
Medtronic PLC (MDT) stock closed down 3.30% on June 30 due to a broader capital rotation out of defensive healthcare stocks into growth sectors, disap...
Neutral
Edwards Lifesciences has received FDA clearance for its Ecliptis left atrial appendage (LAA) exclusion system, positioning it to compete with existing...
Medtronic (MDT) has seen recent optimism due to its renal denervation system and strong revenue growth, despite a previous year-to-date share price de...
Neutral
Medtronic plc's CEO, Geoffrey Martha, announced that the company anticipates a $250 million tariff impact for fiscal 2027, a reduction from a previous...
Neutral
This article provides an overview of Medtronic plc's Unsponsored Brazilian Depository Receipt, MDTC34, on the B3 exchange. It highlights the availabil...
Bullish
Medtronic (MDT) stock is considered 12.2% undervalued, with a fair value of $90.37 per share against its current price of $79.34, despite recent share...
Bullish
Medtronic plc reported its full-year 2026 financial results, with total revenue reaching $36.36 billion and diluted EPS of $3.73, marking a significan...
Bullish
The American Society of Anesthesiologists (ASA) has announced a continued 12-year collaboration with Medtronic, a global leader in healthcare technolo...
Neutral
This article provides a detailed revenue breakdown for Medtronic PLC (MDT) across its various business segments and geographical regions. It highlight...
Bullish
Medtronic has completed its $550 million acquisition of Scientia Vascular, a neurovascular technology company specializing in guidewire technologies f...
Bullish
Medtronic has acquired Scientia Vascular, a company specializing in neurovascular access technologies, for $550 million. This acquisition aims to inte...
Neutral
BofA (Bank of America) reduced its price target on Medtronic (MDT) stock to $95 from $110, while maintaining a "Buy" rating, citing a lower utilizatio...
Bearish
BofA has lowered its price target on Medtronic (MDT) stock to $95 from $110, maintaining a "Buy" rating, due to a lower utilization environment and in...
Neutral
Rhenman & Partners Asset Management AB lifted its holdings in Medtronic PLC (NYSE:MDT – Free Report) by 44.4% in the fourth quarter, according to the ...
Neutral
Vontobel Holding Ltd. significantly increased its stake in Medtronic PLC by 111.7% in the fourth quarter, purchasing 520,768 additional shares and bri...
Bullish
Medtronic plc (NYSE: MDT) has finalized its acquisition of Scientia Vascular for $550 million, plus potential earn-out and milestone payments. This st...
Medtronic has completed its acquisition of Scientia Vascular for $550 million, plus potential earn-outs. This acquisition integrates Scientia's guidew...
Bullish
Medtronic's average 12-month stock price target has been adjusted down to $96.72 from $97.32, according to 25 analysts. This new target suggests a pot...
Bullish
Sector Gamma AS has reduced its stake in Medtronic (MDT) by 11.1% in Q4, but it remains its third-largest holding, representing 5.9% of its portfolio....